Mark For: LIGHTSHIP™ trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88264600 |
Mark Literal Elements | LIGHTSHIP |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-02-11 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Lindsay Cohen Schneider |
Attorney Docket Number | 2400867 |
Law Office Assigned | L40 |
Employee Name | CANTONE, KERI H |
2019-01-16 | Application Filed |
2019-11-13 | Location: PUBLICATION AND ISSUE SECTION |
2019-12-17 | Published |
2019-12-17 | Published for Opposition |
2019-12-17 | Status: Live/Pending |
2019-12-17 | Transaction Date |
2019-12-18 | Trademark Registered |
2020-02-11 | Location: INTENT TO USE SECTION |
2020-08-10 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Party: | ![]() |
Address | 8330 MENLO AVE, SUITE 100 MENLO PARK, CALIFORNIA UNITED STATES 94025 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | IMAGE/JPEG | 2019-01-16 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2019-01-16 |
![]() | MULTI | 2019-04-03 |
![]() | XML | 2019-04-03 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2019-10-01 |
![]() | MULTI | 2019-10-03 |
![]() | XML | 2019-10-04 |
![]() | MULTI | 2019-10-05 |
![]() | MULTI | 2019-10-08 |
![]() | XML | 2019-11-12 |
![]() | XML | 2019-11-12 |
![]() | MULTI | 2019-11-13 |
![]() | MULTI | 2019-11-13 |
![]() | XML | 2019-11-27 |
![]() | XML | 2019-11-27 |
![]() | XML | 2019-12-17 |
![]() | XML | 2020-02-11 |
![]() | XML | 2020-08-10 |
![]() | XML | 2020-08-12 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2020-08-12 |
IC 009. US 021 023 026 036 038. G & S: downloadable computer application software for a cloud-based and web-based telemedicine platform for use in a clinical research; downloadable mobile applications to track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices
IC 035. US 100 101 102. G & S: Business management services, namely, forecasting drug supplies for clinical trials; Business management services, namely, recruiting patients and volunteers for clinical trials; Project management services for others for business purposes in the field of research and development of pharmaceuticals and medical devices; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
IC 042. US 100 101. G & S: Conducting clinical trials for others; Medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; Scientific consulting and research services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; Collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; Virtual consulting services regarding medical and scientific research in relation to clinical trials only; Design and development of software for use in conducting research in clinical and non-clinical pharmaceutical and medical device and development studies; Software as a service (SAAS) services featuring software for use in a telemedicine platform for use in clinical research; Platform as a service (PAAS) featuring computer software platforms for the purposes of exchanging data between the medical care providers, researchers, and patients; Providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; Providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting patient information and healthcare statistics in clinical and non-clinical pharmaceutical and medical device and development studies
IC 044. US 100 101. G & S: Providing telemedicine services to patients; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0091 | downloadable computer application software for a cloud-based and web-based telemedicine platform for use in a clinical research; downloadable mobile applications to track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices |
GS0421 | Software as a service (SAAS) services featuring software for use in a telemedicine platform for use in clinical research; Platform as a service (PAAS) featuring computer software platforms for the purposes of exchanging data between the medical care providers, researchers, and patients |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-12 | |
TEAS EXTENSION RECEIVED | 2020-08-10 | |
EXTENSION 1 GRANTED | 2020-08-10 | 98765 |
EXTENSION 1 FILED | 2020-08-10 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-02-11 | |
PUBLISHED FOR OPPOSITION | 2019-12-17 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-12-17 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-11-27 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-11-12 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2019-11-12 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2019-11-12 | 88579 |
EXAMINER'S AMENDMENT ENTERED | 2019-11-12 | 88888 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-11-12 | |
PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2019-11-07 | |
WITHDRAWN FROM PUB - OG REVIEW QUERY | 2019-10-22 | 99910 |
ASSIGNED TO LIE | 2019-10-10 | 70633 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-10-07 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-10-04 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2019-10-04 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2019-10-04 | 88579 |
EXAMINER'S AMENDMENT ENTERED | 2019-10-04 | 88888 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-02 | 88889 |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-10-02 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-01 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-01 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-04-03 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-04-03 | 88579 |
NON-FINAL ACTION E-MAILED | 2019-04-03 | 6325 |
ASSIGNED TO EXAMINER | 2019-03-28 | 88579 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-02-08 | |
NEW APPLICATION ENTERED IN TRAM | 2019-01-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.